Formial is addressing the difficulty of finding sustained, personalized treatment for acne, pigmentation, scarring, melasma, and aging by combining clinical diagnosis, custom formulations, and ongoing digital care instead of one-size-fits-all products. The company says it has distributed more than 5,000 formulations across more than 87 SKUs, with 40% month-on-month growth and repeat customers contributing 40% of its business, and its Rs 2.88 crore pre-seed round is intended to expand clinical capacity and personalization technology.